Tumor treating fields (TTFields) for patients with glioblastoma

In Switzerland, tumour treating fields (TTFields) for the treatment of newly diagnosed glioblastoma are reimbursed through the statutory health insurance under certain circumstances. To evaluate the reimbursement obligation, a HTA was commissioned with the aim of investigating the efficacy, safety, cost-effectiveness and budgetary impact of TTFields for patients with glioblastoma. As well as the use of TTFields for newly diagnosed glioblastoma, the HTA also examines their use in recurring glioblastoma. The ethical, legal, organisational and social aspects of treatment with TTFields are also evaluated in the HTA report.

Last modification 24.04.2023

Top of page

Contact

Federal Office of Public Health FOPH
Health insurance benefits Division
Health Technology Assessment Section
Schwarzenburgstrasse 157
3003 Bern
Switzerland
Tel. +41 58 469 17 33
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/tumortreatingfields.html